E&C Weighs Orphan Drug, Generic Drug Labeling, Manufacturing Reforms

By Kelly Lienhard / January 28, 2020 at 2:43 PM
The House Energy & Commerce health panel will review legislative proposals that aim to end gaming of the Orphan Drug Act, improve generic drug labeling and foster continuous manufacturing at a legislative hearing Wednesday (Jan. 29). The bills, which if enacted could help lower drug costs by spurring generic drug competition, are among 10 to be reviewed at the hearing, which will focus on ways to improve the safety and transparency of drugs, devices and food . The orphan drug...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.